
A study found mothers with preterm hypertensive disorders of pregnancy had the highest cardiovascular disease mortality risk with larger infants.

A study found mothers with preterm hypertensive disorders of pregnancy had the highest cardiovascular disease mortality risk with larger infants.

A study found that 5 major adverse pregnancy outcomes were linked to increased long-term atrial fibrillation risk.

Researchers found that raising screening rates in federally qualified health centers to national goals could prevent thousands of cancers.

The FDA’s investigational device exemption approval allows FemBloc to enter the final phase of its pivotal trial.

A study found that administering prophylactic antibiotics shortly after a second degree tear lowers the risk of wound complications.

A new study has identified 4 subgroups of polycystic ovary syndrome with unique hormonal and metabolic profiles.

The FDA has approved injectable fosfomycin for adults with complicated urinary tract infections, offering a new treatment option against multidrug-resistant bacteria.

A review identified anxiety, depression, hypertension, OCD, and hemorrhage as the most frequent complications within the first year postpartum.

A study found that taking as few as 4000 steps per day on just 1 to 2 days each week significantly reduces mortality in women aged 62 years and older.

A new study reveals that nearly 20% of urinary tract infections in Southern California may stem from E. coli strains found in contaminated meat.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A new study finds that 1-mg/day dienogest offers comparable pain reduction to a 2-mg/day dose for endometriosis while maintaining a favorable safety profile.

The updated guideline offers evidence-based recommendations for diagnosing and managing menopause.

A large analysis found that stillbirths occur more often than CDC estimates, and many cases lack identifiable clinical risk factors.

Following positive safety and efficacy data, the FDA has approved elinzanetant to manage vasomotor symptoms in postmenopausal women.

A study reveals a sharp rise in telehealth medication abortion use following the Dobbs v Jackson Women’s Health Organization ruling.

A study found that prenatal exposure to antenatal corticosteroids increases the long-term risk of respiratory and nonrespiratory infections.

A study found no link between first-trimester mRNA COVID-19 vaccine exposure and major congenital malformations.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A new study found that the severity of pelvic pain in patients with endometriosis affects health-related quality of life through the influence of coping mechanisms.

New research from Penn State reveals that endometriosis disrupts the autonomic nervous system, offering clues for earlier diagnosis.

A national survey found that over half of Americans mistakenly believe women cannot safely give birth in their 40s.

A study highlights the need for culturally responsive, patient-centered care to address the experiences of Black women with endometriosis.

A study found that individuals’ ability to achieve their pregnancy preferences differs across sociodemographic factors.

Women with prior cesarean delivery are more likely to experience severe pain, sleep disturbances, and daily activity disruption postpartum.

Women who undergo cesarean delivery during advanced labor face a greater risk of scarring that may increase preterm birth risk in future pregnancies.

Researchers from found that hormone replacement therapy may restore immune function changes linked to menopause.

A study found that while women show faster reaction times during ovulation, regular physical activity has a greater impact on enhancing cognitive function.

New reveals that nearly one-third of patients with long COVID develop postural orthostatic tachycardia syndrome.

Women undergoing mastectomy face greater risks of emotional distress, physical symptoms, and reduced quality of life compared with breast-conserving procedures.